Glenmark Pharmaceuticals has informed that the Nomination & Remuneration Committee of the Company, at its meeting held on November 2, 2017 has allotted 25,306 stock options pursuant to Employee Stock Options Scheme, 2016.
The above information is a part of company’s filings submitted to BSE.